Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
Abstract Background Breast cancer (BC) is a highly heterogeneous disease. Among the BC molecular subtypes, basal-like/triple-negative BC (TNBC) is characterized by a high propensity for relatively early metastases and a lack of available endocrine and targeted therapies. Therefore, this study aimed...
Main Authors: | Min Wu, Keyu Yuan, Shuzhen Lyu, Yanping Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02683-2 |
Similar Items
-
Triple Negative Breast Cancer Characteristics Based on Basal-like and Non-Basal-like Subtypes
by: Fifi Akwarini, et al.
Published: (2019-05-01) -
Programmed death ligand-1 protein expression difference in basal like and non-basal like triple negative breast cancer and its association with disease free survival and overall survival: A systematic review
by: Freda Halim, et al.
Published: (2021-09-01) -
Current and emerging treatment options in triple-negative breast cancer
by: Omer Dizdar, et al.
Published: (2011-12-01) -
A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01) -
Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation
by: Man Zou, et al.
Published: (2017-11-01)